: QQ--plot for categorical phenotype analyses. PCDH10 PCDH10  PHYHIP PHYHIP  RGS20 RGS20  GLRB GLRB   PTPRD PTPRD  KNDC1 KNDC1  APBB1 APBB1  NCS1 NCS1  AMPH AMPH  GRIK2 GRIK2  IQCK IQCK  CAMK1G CAMK1G  LGI1 LGI1  GRIA4 GRIA4  DLGAP1 DLGAP1  CIT CIT  BAI2 BAI2  ITSN1 ITSN1  NEUROD6 NEUROD6  LIN7B LIN7B  PPP5C PPP5C  OFCC1 OFCC1 b) DLGAP1-GRIK2 module + miRNA sets module (nominal significant genes each) with OCGAS top hits. 2) Legends for supplementary tables S1--S4: Table S1 : Sample breakdown. Breakdown of sample by study center and recruitment timing. Table S2 : Annotation of OCGAS GWAS signals. Clumps (CLUMP) of markers are listed with the lead marker (SNP) showing an association P--values less then 1 x 10 --5 for hybrid analysis of within and between family component in the OCGAS GWAS. The chromosome (CHR) and base pair location (BP) for each SNP are listed together with the effect allele (MA) and the frequency of the effect allele in the additional controls in the OCGAS GWAS (MAF). In addition, the number of informative families (INFO) and the number of additional SNPs in the clumps (N; see table 2 of the manuscript for a detailed description of the clumping process) are provided. Direction of effects (DIR) indicates whether the direction of association between OCD and the effect allele (MA) is either positive (+) or negative (--) in the within family component and between family component, respectively. Annotations of GWAS signals are provided using the SCAN database (SCAN DB ANNOTATIONS) or the SPOT database (SPOT ANNOTATION). The gene (for variants located within a gene specific feature) together with the flanking genes (left_gene and right_gene; distance in kilobases are provided) are annotated. QTL columns list genes whose expression (eQTL) are associated (P--value) with the specified SNP in that row and for the specific ethnicity. Finally, genes are annotated that harbor a SNP that is in LD with the query SNP (genes(rsq)). In case of the SPOT annotation query SNPs and their proxies are given together with the gene function and a Polyphen prediction as provide by SPOT. Table S3 : Results for miRNA sets. Gene--based results are given (FORGE analyses of OCGAS GWAS, for more details refer to main manuscript) for a list of high confidence targets (Aggregate P ct > 0.9 in TargetScan) of the miRNA families that were previously shown to be enriched for OCD GWAS association signals (Stewart et al. 2013 ). Together with the raw p--value for the gene (geneP) a p--value is given that is corrected for the number of tests within a miRNA set (geneP_all). The p--value for the lead SNP annotated to the gene (SNP with smallest p--value) is given (minP) along with the p--value that is corrected for the number of tests (N = number of SNPs annotated to the gene) within the gene (minP_gene) and for all SNPs tested in the miRNA set (minP_all). Bold marked genes are nominal significant, bold red genes are experiment--wise significant for the miRNA set. Table S4 : Results for high confidence interactors of DLGAP1 and GRIK2. Gene--based results are given (FORGE analyses of OCGAS GWAS, for more details refer to main manuscript) for a list of high confidence interactors (P fc > 0.95 in FUNCOUP analyses) of DLGAP1 and GRIK2 (more details on the selection process is provided below in the material and methods section of the supplementary information). For each gene its chromosome (CHR) and START and STOP positions (hg19) are listed. Together with the p--value for the gene (geneP) the p--value for the lead SNP annotated to the gene (SNP with smallest p--value) is given (minP) along with the number of SNPs (N) annotated to the gene.
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3) Legends for supplementary figures S1--S4:
Figure S1: QQ--plot for categorical phenotype analyses. Plotted are negative decadic logarithms of the expected vs. observed test statistics (P) in the hybrid analysis (within + between family component) for the OCGAS GWAS. As expected, the plot follows the red line (bisecting line) and thus stratification does not appear to be present. S3 ). Color of the edges in the network indicate source for "interaction": Purple = Co--expression; Blue = Co--localization; Green = Genetic interactions; Red = Physical interaction; and Brown = Shared protein domains. Standard parameters were used for query (i.e.: automatically query dependent weighting of the network connections; default network resources; no attributes), but no other genes were added to the network (0 "related genes").
4) Supplementary Materials and Methods

Diagnostic assessment of OCGAS sample
Each case was evaluated by a MD--or PhD--level clinical psychologist using the Structured Clinical
Interview for DSM--IV (SCID). The checklist of obsessions and compulsions from the Y--BOCS, refined to include the age of onset, offset, and severity of each symptom, as well as the Y--BOCS scores for the worst episode (lifetime) was recorded. Course and treatment response variables were also included. A similar model was used for evaluating tics and Tourette disorder. Axis I disorder diagnoses were assigned using the JHU Diagnostic Assignment Checklist, an instrument that documents the criteria for over 20 DSM--IV disorders; this instrument also was the primary tool for the diagnostic consensus procedure. The SCID--II was used to evaluate four personality disorders (schizotypal, obsessive--compulsive, avoidant, and dependent), and the FISC was used to obtain additional information about each participant from a knowledgeable informant Children over the age of eight were assessed in the same way, except that the Kiddie--SADS was used in place of the SCID.
Final diagnostic status was assigned based on the consensus of two psychiatrists or psychologists reviewing the case independently. The agreement between diagnosticians using the Diagnostic Assignment Checklist has been studied and found to be excellent for variables such as age at onset of OCD. The chance--corrected percent agreement between the diagnosticians for the diagnosis of OCD was κ= 0.92; for age at onset of OCD, k=0.88 (for age +/--5 years), and Pearson's r=0.71. The diagnostic information from each site was reviewed by one of the five members of the JHU diagnostic consensus committee to ensure comparability across sites.
Genotyping of OCGAS sample
DNA was extracted at Rutgers University from whole blood and EBV transformed cell lines on an AutoPure LS automated DNA extractor using the PuraGene Reagent System (GENTRA Systems, Minneapolis, MN, USA). RNase was added to the WBC lysis stage with isopropanol precipitation of the DNA and re--suspension in 1X TE Buffer (pH 8.0). DNA was quantified by OD at 260nm on a DU--640 spectrophotometer (Beckman, Brea, CA, USA) and OD 260/280 absorbance ratios were between 1.8--2.0.
DNA was aliquoted and stored frozen at --800C until distributed to the genotyping labs. 
Potential bias through inclusion of our additional controls
The inclusion of additional controls into our analysis might have introduced a potential bias, as these controls have not been adequately screened for OCD symptoms. Inclusion of (population based)
controls from previous studies is a common procedure in GWAS analyses. Although obviously not an optimal solution, it seems to be accepted that doing so provides more advantages then it imposes difficulties. In particular, assuming that most sources of technical biases (e.g. based on different genotyping arrays in use, different protocols at the genotyping centers etc.) are taken care of, then for disorders with a reasonably low prevalence (i.e. resulting in a small number of un--intentional cases in the control population) only minor changes in the power of the study are to be expected. We chose our additional controls to match our own data as much as possible. This included most of the potential technical biases (same genotyping array was used, same genotyping center) and also we tried to come close to a screened design choosing a dataset that was used in a neuropsychiatric study. Obviously we couldn't control all parameters and therefore it seems reasonable to assume that we might have included a few OCD samples in the control group. While this potentially results in a bias, this bias will add to the false negative, rather then false positive findings and therefore should be negligible.
QC protocol for OCGAS GWAS
As part of this protocol, the X--chromosomal data (excluding the pseudo--autosomal regions) was used to determine the sex of all individuals on the basis of heterozygosity rates. The results were compared with the phenotypic sex reported by the clinical centres and individuals with discrepancies in either were removed in case the discrepancy could not be explained (and otherwise updated using the sex that was determined on the basis of heterozygosity rates). Individuals with excessive missing genotypes (call rate <0.98) were removed. The identity by state (IBS) matrix (all combinations of subjects) was computed and pairs of cryptic (and intentional) duplicated individuals within the additional controls or between our independent study samples (OCGAS samples and additional controls) were identified. One member of each pair was removed (with a preference for keeping the OCGAS samples whenever possible). In addition, we used this information to check for discrepancies in the relationship information reported by the clinical centres and the relationship determined using the information from the IBS matrix. For those individuals / families with discrepancies the pedigree information was re--evaluated and in case no explanation could be found the families were removed from the analysis. Furthermore, individuals were removed if case analyses revealed an excess of potential genotyping errors on the basis of parental transmission (check for "Mendelian inconsistencies"). Please note that this process was conducted twice and iteratively with respect to the same analysis based on the SNP information (see below). Although inherently robust against population stratification a substantial heterogeneity in the population based study cohorts leads to a decreased power for our analytical approach (see below). We have therefore performed a multidimensional scaling (MDS) analysis to identify possible stratification between the probands that were not connected to a pedigree (either intentionally or as a consequence of the QC process) and the additional independent control samples. We removed all individuals that were identified as outliers based on the first two dimensions from the MDS analyses (12 individuals in total, 6 probands and 6 controls). At the SNP level we removed markers with excessive missing genotypes (call rate <0.98) and SNPs monomorphic in the OCGAS sample and/ or the additional independent controls.
Further SNPs were excluded due to an excess of Mendelian inconsistencies in the OCGAS samples following exclusion of individuals with an excess of Mendelian inconsistencies (see above). SNPs with MAFs <5% in the founders of the OCGAS samples or MAFs <1% in the additional independent controls were excluded. SNPs were excluded on the basis of deviations from HWE (P exact < 1 x 10 --10 in the founders of the OCGAS samples, and P exact < 1 x 10 --6 in the additional controls).
Analyses stratified by sex
In addition to our analyses using the entire dataset we also analyzed the data stratified by sex. For the purpose of these analyses we used two different group definitions (females only and males only) and performed the same single--marker analyses that are outlined for the entire sample. An overview of the results for these analyses can be found in the Supplementary  Figures  S2a  (females) and S2b (males). In sum, our analyses did not identify a genetic variation with sex specific effects at the level of genome--wide significance.
For the female only analysis, the most prominent signal was observed for the chromosome 16 region that harbors the IQ motif containing K gene (IQCK; rs11865578; P female = 2.84 x 10 --6 ; P male = 0.3196; P all = 1.28 x 10 --4 ). The strongest signal for the entire sample (i.e. females and males) in this region was observed for a SNP (rs1544352; P female = 2.15 x 10 --5 ; P male = 0.0190; P all = 1.94 x 10 --5 ) in moderate LD with the aforementioned SNP (R 2 = 0.547, D' = 0.805 based 1000 Genomes project information for the CEU sample 1 ). The strongest signal for the males only analysis in this region (+/--500kb from rs1544352) was observed for rs179196 (R 2 = 0.015, D' = 1.000 with rs1544352 based 1000 Genomes project information for the CEU sample; P female = 0.2474; P male = 7.14 x 10 --4 ; P all = 0.2939). It is of note, that IQCK was recently identified as an interaction partner of the nuclear receptor coactivator 3 (NCOA3) 2 . NCOA3 has recently been described to play a role in maintenance of pluripotency of embryonic stem cells 3 . Moreover, it has been described that sex steroid hormones in astrocytomas differentially regulate NCOA3 expression 4 .
However, not much is known about the impact of the interaction of IQCK and NCOA3 in these processes or a potentially sex specific role of IQCK. Further potentially interesting signals in the female only GWAS included variation on chromosomes 5 (rs10477635; near SNCAIP; P female = 6.49 x 10 --6 ), 4 (rs6843954; near ACSL1; P female = 6.63 x 10 --6 ), and 8 (rs6473190; near HEY1; P female = 6.76 x 10 --6 ).
For the male only analysis, the strongest signal was found for genetic variation on chromosome 10 (rs12777323; near GRID1; P male = 2.84 x 10 --6 ; P female = 0.5163; P all = 0.1817). While the glutamate receptor delta 1 gene locus (GRID1) has bot been implicated in the etiology of OCD before, it was previously
shown, that GRID1 is associated with schizophrenia 5, 6 .
Visualization of network / interactome data
We used GENEMANIA (genemania.org) 7 to visualize the interaction of query genes based on information from different integrated datasets. More information about these datasets can be found at genemania.org (data accessed 06/2013). In brief, publicly available data for co--expression, co--localization, genetic interactions, pathways, physical interactions and protein domain similarity are used to connect a list of query genes and visualize their interactions, i.e. providing information on their shared biological and functional background. Since we were interested in pure visualization of the data and did not want to identify further related genes, we choose to restrict the resulting network to the query genes themselves. For a first run we used a query list comprising nominal significant genes in the analyses of DLGAP1 and GRIK2 interactors (see supplementary table S4) and our own genes of interest (PTPRD, IQCK, OFCC1, DLGAP1, GRIK2).
As expected, the available information in GENEMANIA 7 resembled the information on high confident interactors for DLGAP1 and GRIK2 from FUNCOUP 2. We used two different resources (FUNCOUP 2.0 and GENEMANIA) to incorporate a priori knowledge about potential interplay / interactions of genes that have been highlighted by our study. This design was chosen to allow for a robust assessment of a set of interactors (disease modules) for OCD. We acknowledge that the information used by FUNCOUP 2.0 and GENEMANIA does overlap to some extent and is incomplete when it comes to disease specific information 7, 8 . Moreover, it is reasonable to assume that both databases are subject to biases introduced by predominantly including highly studied interactions. In light of these limitations more work is needed to assess sets of GRIK2 and DLGAP1 interactors for OCD. However, we would like to stress that information from network topology and the human interactome, even when incomplete, is still valuable. It can help to prioritize genes for downstream analyses, especially in cases where genetic information alone is not able to pinpoint disease--causing genes.
